Hematopoietic Recovery Following Induction Therapy of Acute Leukemias: Prognostic Implications and a New Look at the Definition of Remission

References

• Buggins, A.G., Milojkovic, D., Arno, M.J., Lea, N.C., Mufti, G.J., Thomas, N.S., et al. (2001) "Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways", Journal of Immunology, 167, 6021 — 6030.
   Google Scholar
• Litwin, C., Leong, KG., Zapf, R., Sutherland, H., Naiman, S.C. and Karsan, A. (2002) "Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia", American Journal of Hematology, 70, 22— 30.
   Google Scholar
• Leith, C.P. and Willman, C.L. (1996) "Prognostic markers in acute leukemia", Current Opinion in Hematology, 3, 329–334.
   PubMedGoogle Scholar
• Hoelzer, D. and Gokbuget, N. (2000) "Recent approaches in acute lymphoblastic leukemia in adults", Critical Review in Oncology/ Hematology, 36, 49–58.
   PubMed Web of Science ®Google Scholar
• Estey, E.H. (2001) "Prognostic factors in acute myelogenous leukemia", Leukemia, 15, 670–672.
   Google Scholar
• Verma, A. and Stock, W. (2001) "Management of adult acute lymphoblastic leukemia: moving toward a risk adapted approach", Current Opinion in Oncology, 13, 14–20.
   PubMed Web of Science ®Google Scholar
• Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., et al. (1990) "Report of the National Cancer Institute-Sponsored Workshop on definitions of diagnosis and response in acute myeloid leukemia", Journal of Clinical Oncology, 8, 813–819.
   Google Scholar
• Southam, C.M., Craver, L.F., Dargeon, H.W. and Burchenal, J.H. (1951) "A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions", Cancer, 4, 39–59.
   Google Scholar
• Bisel, H.F. (1956) "Criteria for the evaluation of response to treatment in acute leukemia", Blood, 11, 676–677.
   Google Scholar
• Freireich, E.J., Gehan, E.A., Sulman, D., Boggs, D.R. and Frei, E. III (1961) "The effect of chemotherapy on acute leukemia in the human", Journal of Chronic Diseases, 14, 593
   PubMedGoogle Scholar
• Estey, E.H., Giles, F., Cortes, J., Beran, M., Verstovsek, S., Garcia-Manero, G., et al. (2003) "Empirical examination of the neutrophil criterion ( 1500 pl —1) currently needed to declare CR in AML", Leukemia Research, 27, 475–479.
   PubMed Web of Science ®Google Scholar
• Estey, E.H., Kantarjian, H.M., Cortes, J., Thomas, D., Verstovsek, S., Pierce, S., et al. (2002) "Is the absence of circulating blasts a valid criterion for CR in AML", Blood, 100, 88a.
   Google Scholar
• Faderl, S. and Estrov, Z. (1998) "The clinical significance of detection of residual disease in childhood ALL", Critical Review in Oncology and Hematology, 28, 31 — 55.
   PubMed Web of Science ®Google Scholar
• Estey, E.H., Shen, Y. and Thall, P.F. (2000) "Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB", Blood, 95, 72–77.
   Google Scholar
• Rautonen, J., Hovi, L. and Siimen, M.A. (1988) "Slow disappear-ance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia", Blood, 71, 989–991.
   Google Scholar
• Lilleyman, JS., Gibson, B.E., Stevens, R.F., Will, A.M., Hann, TM., Richards, S.M., et al. (1997) "Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia", British Journal of Haematology, 97, 603–606.
   PubMed Web of Science ®Google Scholar
• Gajjar, A., Ribeiro, R., Hancock, M.L., Rivera, G.K., Mahmoud, H., Sandlund, J.T., et al. (1995) "Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia", Blood, 86, 1292–1295.
   PubMed Web of Science ®Google Scholar
• Kern, W., Haferlach, T., Schoch, C., Löffler, H., Gassmann, W., Heinecke, A., et al. (2003) "Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial", Blood, 101, 64–70.
   Google Scholar
• Faderl, S., Thall, P.F., Kantarjian, H.M. and Estrov, Z. (2002) "Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukemia who have achieved a complete remission", British Journal of Haematology, 117, 869–874.
   Google Scholar
• Pui, C.-H. and Campana, D. (2000) "New definition of remission in childhood acute lymphoblastic leukemia", Leukemia, 14, 783–785.
   Google Scholar
• Miyamoto, T., Weissmann, I.L. and Akashi, K. (2000) "AML1/ ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation", Proceedings of the National Academy of Sciences of the United States of America, 97, 7521 — 7526.
   Google Scholar
• Radich, J. (2000) "Clinical applicability of the evaluation of minimal residual disease in acute leukemia", Current Opinion in Oncology, 12, 36–40.
   PubMed Web of Science ®Google Scholar